Frequently Asked Questions
The market is segmented based on , By Product (Oligonucleotide, Reagents, and Equipment), Type (Custom Oligos and Predesigned Oligos), Application (Therapeutic Applications, Diagnostics, Research, and Others), End User (Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories, and Others) – Industry Trends and Forecast to 2031.
.
The Global Oligonucleotide Synthesis Market size was valued at USD 7.70 USD Billion in 2022.
The Global Oligonucleotide Synthesis Market is projected to grow at a CAGR of 11.8% during the forecast period of 2023 to 2030.
The major players operating in the market include Agilent Technologies , Atdbio , LGC Limited, BioSynthesis , Eurofins Genomics, Kaneka Eurogentec S.A., General Electric, Genscript, AJINOMOTO CO. , Danaher, Merck Kgaa.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.
